| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Successes and challenges of HIV prevention in men who have sex with men.
|
Lancet
|
2012
|
4.94
|
|
2
|
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
|
PLoS Med
|
2008
|
2.74
|
|
3
|
Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.
|
AIDS
|
2006
|
1.88
|
|
4
|
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy.
|
PLoS One
|
2011
|
1.84
|
|
5
|
Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF.
|
AIDS
|
2002
|
1.78
|
|
6
|
RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate.
|
AIDS Res Hum Retroviruses
|
2012
|
1.67
|
|
7
|
Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals.
|
J Acquir Immune Defic Syndr
|
2006
|
1.63
|
|
8
|
Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.
|
J Virol
|
2005
|
1.54
|
|
9
|
Reverse transcriptase inhibitors as potential colorectal microbicides.
|
Antimicrob Agents Chemother
|
2009
|
1.26
|
|
10
|
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.
|
J Acquir Immune Defic Syndr
|
2010
|
1.24
|
|
11
|
HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
|
AIDS
|
2007
|
1.22
|
|
12
|
Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.
|
AIDS Behav
|
2009
|
1.20
|
|
13
|
Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study.
|
AIDS Res Hum Retroviruses
|
2012
|
1.14
|
|
14
|
"Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.
|
AIDS Behav
|
2012
|
1.11
|
|
15
|
Modeling the potential impact of rectal microbicides to reduce hiv transmission in bathhouses.
|
Math Biosci Eng
|
2006
|
1.06
|
|
16
|
Extended treatment with tenofovir disoproxil fumarate in treatment-experienced HIV-1-infected patients: genotypic, phenotypic, and rebound analyses.
|
J Acquir Immune Defic Syndr
|
2003
|
1.04
|
|
17
|
Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.
|
Cult Health Sex
|
2011
|
1.04
|
|
18
|
Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.
|
AIDS
|
2011
|
1.01
|
|
19
|
Advances in the Development of Microbicides for the Prevention of HIV Infection.
|
Curr Infect Dis Rep
|
2010
|
0.99
|
|
20
|
Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice.
|
PLoS One
|
2013
|
0.93
|
|
21
|
Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research.
|
AIDS Behav
|
2014
|
0.92
|
|
22
|
Implications of HIV PrEP trials results.
|
AIDS Res Hum Retroviruses
|
2010
|
0.92
|
|
23
|
Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics.
|
J Biol Chem
|
2010
|
0.92
|
|
24
|
An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site.
|
Virology
|
2008
|
0.91
|
|
25
|
Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.
|
AIDS Behav
|
2014
|
0.85
|
|
26
|
Long-acting rilpivirine for HIV prevention.
|
Curr Opin HIV AIDS
|
2015
|
0.82
|
|
27
|
Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007).
|
AIDS Behav
|
2013
|
0.81
|
|
28
|
Microbicides 2006 conference.
|
AIDS Res Ther
|
2006
|
0.80
|
|
29
|
The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.
|
World J AIDS
|
2013
|
0.79
|
|
30
|
Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotyped lentiviral vectors.
|
BMC Gastroenterol
|
2010
|
0.79
|
|
31
|
Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study.
|
Sex Transm Dis
|
2015
|
0.75
|
|
32
|
Correction: Musosal effects for tenofovir 1% gel.
|
Elife
|
2015
|
0.75
|
|
33
|
A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD.
|
Dis Colon Rectum
|
2017
|
0.75
|